Biolife Solutions Inc

Biolife Solutions Inc

BLFS

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.78B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biolife Solutions IncBiolife Solutions Inc35.2-12%18-
$31.00

Target Price by Analysts

13.7% downsideBiolife Solutions Target Price DetailsTarget Price
$-1.38

Current Fair Value

103.8% downside

Overvalued by 103.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.78 Billion
Enterprise Value$1.77 Billion
Dividend Yield$- (-)
Earnings per Share$-0.25
Beta1.9
Outstanding Shares48,866,822

Return

Return on Equity12.01%ROE
Return on Assets11.27%
Return on Invested Capital1.59%

Valuation & Multiples

P/E Ratio35.18P/E Ratio
PEG-9.14PEG
Price to Sales17.96Price to Sales
Price to Book Ratio4.49Price to Book Ratio
Enterprise Value to Revenue17.21
Enterprise Value to EBIT255.85
Enterprise Value to Net Income35
Total Debt to Enterprise0.01
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$0.03
Average shareholder expectation
Revenue Estimate
$27.80 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$0.01
Average shareholder expectation
Revenue Estimate
$29.17 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.6818 68.18%
Total Calls85,800 Infinity%
Total Puts58,500 Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %105.33% 0.86%
Total Invested$1.45B 52.30%
Investors Holding220 33.00%

ESG Score

No data

About Biolife Solutions Inc

CEO: Michael Rice